Mesenchymal stem cells deliver exogenous microRNA-let7c via exosomes to attenuate renal fibrosis B Wang, K Yao, BM Huuskes, HH Shen, J Zhuang, C Godson, ... Molecular Therapy 24 (7), 1290-1301, 2016 | 369 | 2016 |
Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage and dysfunction in salt-sensitive hypertension SM Krishnan, YH Ling, BM Huuskes, D Ferens, N Saini, CT Chan, H Diep, ... Cardiovascular Research, 2018 | 261 | 2018 |
Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis AA Pinar, TE Scott, BM Huuskes, FET Cáceres, BK Kemp-Harper, ... Pharmacology & Therapeutics, 107511, 2020 | 85 | 2020 |
Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy BM Huuskes, AF Wise, AJ Cox, EX Lim, NL Payne, DJ Kelly, CS Samuel, ... The FASEB Journal 29 (2), 540-553, 2015 | 84 | 2015 |
Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease SG Royce, M Shen, KP Patel, BM Huuskes, SD Ricardo, CS Samuel Stem cell research 15 (3), 495-505, 2015 | 45 | 2015 |
Serelaxin improves the therapeutic efficacy of RXFP1-expressing human amnion epithelial cells in experimental allergic airway disease SG Royce, AM Tominaga, M Shen, KP Patel, BM Huuskes, R Lim, ... Clinical Science 130 (23), 2151-2165, 2016 | 17 | 2016 |
The use of live cell imaging and automated image analysis to assist with determining optimal parameters for angiogenic assay in vitro BM Huuskes, RJ DeBuque, PG Kerr, CS Samuel, SD Ricardo Frontiers in cell and developmental biology 7, 45, 2019 | 14 | 2019 |
Endothelial Progenitor Cells and Vascular Health in Dialysis Patients BM Huuskes, RJ DeBuque, KR Polkinghorne, CS Samuel, PG Kerr, ... Kidney International Reports, 2017 | 3 | 2017 |
SUN-139 THE ROLE OF THE INTERLEUKIN-18 RECEPTOR IN EXPERIMENTAL KIDNEY DISEASE J Thomas, P Sharam, C Sobey, G Drummond, A Vinh, B Huuskes Kidney International Reports 4 (7), S216, 2019 | | 2019 |
Renal Microvascular Rarefaction Accompanies Interstitial Fibrosis and Tubular Damage in One Kidney-Deoxycorticosterone Acetate-Salt (1K/DOCA/salt)-Dependent Hypertension N Saini, J Thomas, B Huuskes, P Sharma, C Sobey, A Vinh, G Drummond The FASEB Journal 33 (1_supplement), lb533-lb533, 2019 | | 2019 |
A CRUCIAL ROLE FOR INTERLEUKIN-18 IN THE DEVELOPMENT OF RENAL INFLAMMATION AND ELEVATED BLOOD PRESSURE IN 1 KIDNEY/DOCA/SALT-INDUCED HYPERTENSION J Thomas, YH Ling, S Krishnan, D Ferens, B Kemp-Harper, C Sobey, ... NEPHROLOGY 23, 11-11, 2018 | | 2018 |
PATIENT-DERIVED ENDOTHELIAL CELL FUNCTION IS PREDICTED BY CONTROLLED BLOOD PRESSURE BM Huuskes, PG Kerr, CS Samuel, SD Ricardo NEPHROLOGY 22, 52-53, 2017 | | 2017 |
The therapeutic effects of cell therapy in combination with antifibrotics to enhance tissue repair in experimental kidney disease B HUUSKES Monash University, 2017 | | 2017 |
INCREASED ANGIOGENIC POTENTIAL OF ENDOTHELIAL PROGENITOR CELLS ISOLATED FROM PATIENTS WITH END-STAGE KIDNEY DISEASE USING CELLULAR THERAPY B Huuskes, P Kerr, C Samuel, S Ricardo NEPHROLOGY 21, 145-145, 2016 | | 2016 |
Cell Based Therapy In Combination With Serelaxin Is Critical For Preservation Of Vascular Integrity Via Promotion Of Angiogenesis And Anastomosis B Huuskes, A Pinto, C Samuel, S Ricardo Nephrology 20, 23, 2015 | | 2015 |
FO010ENGINEERED MESENCHYMAL STEM CELLS RELEASE EXOGENOUS MICRORNA LET-7C TO COMBAT KIDNEY FIBROSIS B Wang, Y Kevin, B Huuskes, A Wise, S Ricardo Nephrology Dialysis Transplantation 30 (suppl 3), iii4-iii5, 2015 | | 2015 |
an Innovative Microrna Delivery System Using Engineered Mesenchymal Stem Cells To Combat Kidney Fibrosis: 090 B Wang, AF Wise, K Yao, B Huuskes, SD Ricardo Nephrology 19, 41, 2014 | | 2014 |
Combined Therapy Of Mesenchymal Stem Cells And The Hormone Relaxin Attenuate Renal Fibrosis B Huuskes, A Wise, A Cox, E Lim, N Payne, C Samuel, S Ricardo Nephrology 19, 18-19, 2014 | | 2014 |
Mesenchymal stromal cells targeting kidney disease BM Huuskes, SD Ricardo The Biology and Therapeutic Application of Mesenchymal Cells, 754-769, 0 | | |